Hannes van der Merwe

Dr. Hannes van der Merwe

Universitair Ziekenhuis Leuven, Leuven, Belgium
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2010 in Hypertension in Pregnancy
Verified
Journal Article
Closed access
HMHannes van der Merwe
Hannes van der Merwe
DHD. R. Hall
D. R. Hall
CWC. Wright
C. Wright
PSP. Schubert
P. Schubert
DGD. Grové
D. Grové
To compare histopathological differences in placentas from early- and late-onset preeclampsia, as well as late-onset preeclampsia and normal term deliveries. This prospective study was performed at Tygerberg Hospital, a secondary and tertiary referral center in South Africa. Placentas from 100 women, 25 each with early and late-onset preeclampsia, and an equal number of controls matched for gestational age, underwent routine preparation and were evaluated independently by two pathologists in a strictly predetermined, standardized manner. Compared to late preeclampsia, placentas in the early preeclampsia group were smaller (p < 0.01), had more infarction (odds ratio [OR] = 4.03, 95% confidence interval [CI] = 1.2-13.5) and inappropriate maturation (OR = 16.62, 95% CI = 4.1-68.0). Placentas from the late-onset preeclampsia group showed increased decidual arteriopathy (OR = 5.09, 95% CI = 1.45-17.92) and abruptio placentae (OR = 5.41, 95% CI = 1.01-28.79) compared to controls. The early- and late-onset preeclampsia placentas showed clear histopathological differences, whereas late-onset preeclampsia and normal term placentas differed less. These findings support the contention that early- and late-onset preeclampsia are different subclasses of disease.

1 July 2019 in Best Practice & Research Clinical Obstetrics & Gynaecology
Verified
Journal Article
Closed access
DBDavid Basurto
David Basurto
FRFrancesca Maria Russo
Francesca Maria Russo
LVLennart Van der Veeken
Lennart Van der Veeken
HMHannes van der Merwe
Hannes van der Merwe
SHStuart Hooper
Stuart Hooper
JDJan Deprest
Jan Deprest

27 June 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
LJLuc Joyeux
Luc Joyeux
AEAlexander C. Engels
Alexander C. Engels
HMHannes van der Merwe
Hannes van der Merwe
MAMichael Aertsen
Michael Aertsen
PPPremal A. Patel
Premal A. Patel
JDJan Deprest
Jan Deprest
A randomized trial demonstrated that fetal spina bifida (SB) repair is safe and effective yet invasive. New less invasive techniques are proposed but are not supported by adequate experimental studies. A validated animal model is needed to bridge the translational gap to the clinic and should mimic the human condition. Introducing a standardized method, we comprehensively and reliably characterize the SB phenotype in two lamb surgical models with and without myelotomy as compared to normal lambs. Hindbrain herniation measured on brain magnetic resonance imaging (MRI) was the primary outcome. Secondary outcomes included gross examination with cerebrospinal fluid (CSF) leakage test, neurological examination with locomotor assessment, whole-body MRI, motor and somatosensory evoked potentials; brain, spinal cord, hindlimb muscles, bladder and rectum histology and/or immunohistochemistry. We show that the myelotomy model best phenocopies the anatomy, etiopathophysiology and symptomatology of non-cystic SB. This encompasses hindbrain herniation, ventriculomegaly, posterior fossa anomalies, loss of brain neurons; lumbar CSF leakage, hindlimb somatosensory-motor deficit with absence of motor and somatosensory evoked potentials due to loss of spinal cord neurons, astroglial cells and myelin; urinary incontinence. This model obtains the highest validity score for SB animal models and is adequate to assess the efficacy of novel fetal therapies.

10 December 2019 in Pediatric Research
Verified
Journal Article
Closed access
PDF file
HMHannes van der Merwe
Hannes van der Merwe
ASAdalina Sacco
Adalina Sacco
JTJaan Toelen
Jaan Toelen
JDJan Deprest
Jan Deprest

1 October 2019 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
LVLennart Van der Veeken
Lennart Van der Veeken
HMHannes van der Merwe
Hannes van der Merwe
SDSarah Devroe
Sarah Devroe
AIAnnalisa Inversetti
Annalisa Inversetti
AGAngela Galgano
Angela Galgano
JDJan Deprest
Jan Deprest

18 July 2021 in Prenatal Diagnosis
Verified
Journal Article
Open access
PDF file
NCNeeltje Crombag
Neeltje Crombag
ASAdalina Sacco
Adalina Sacco
BSBernadette Stocks
Bernadette Stocks
PVPhilippe De Vloo
Philippe De Vloo
HMHannes van der Merwe
Hannes van der Merwe
JDJan Deprest
Jan Deprest
Objective: To explore the concepts and strategies parents employ when considering maternal‐fetal surgery (MFS) as an option for the management of spina bifida (SB) in their fetus, and how this determines the acceptability of the intervention.Methods: A two‐centre interview study enrolling parents whose fetuses with SB were eligible for MFS. To assess differences in acceptability, parents opting for MFS (n = 24) were interviewed at three different moments in time: prior to the intervention, directly after the intervention and 3‐6 months after birth. Parents opting for termination of pregnancy (n = 5) were interviewed only once. Themes were identified and organised in line with the framework of acceptability.Results: To parents opting for MFS, the intervention was perceived as an opportunity that needed to be taken. Feelings of parental responsibility drove them to do anything in their power to improve their future child’s situation. Expectations seemed to be realistic yet were driven by hope for the best outcome. None expressed decisional regret at any stage, despite substantial impact and, at times, disappointing outcomes. For the small group of participants, who decided to opt for termination of pregnancy (TOP), MFS was not perceived as an intervention that substantially could improve the quality of their future child’s life.Conclusion: Prospective parents opting for MFS were driven by their feelings of parental responsibility. They recognise the fetus as their future child and value information and care focusing on optimising the child’s future health. In the small group of parents opting for TOP, MFS was felt to offer insufficient certainty of substantial improvement in quality of life and the perceived severe impact of SB drove their decision to end the pregnancy.